These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 25447794)

  • 41. Diabetic nephropathy and beta-cell replacement therapy.
    de Fijter JW
    Neth J Med; 2004 Mar; 62(3):71-5. PubMed ID: 15209470
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Interdisciplinary interaction in vascular diseases of the eye, diabetes and diabetic retinopathy].
    Kleophas W; Dellanna F
    Ophthalmologe; 2014 Jan; 111(1):19-22. PubMed ID: 24448811
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diabetes Mellitus Review.
    Blair M
    Urol Nurs; 2016; 36(1):27-36. PubMed ID: 27093761
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Retinal vessel calibers predict long-term microvascular complications in type 1 diabetes: the Danish Cohort of Pediatric Diabetes 1987 (DCPD1987).
    Broe R; Rasmussen ML; Frydkjaer-Olsen U; Olsen BS; Mortensen HB; Hodgson L; Wong TY; Peto T; Grauslund J
    Diabetes; 2014 Nov; 63(11):3906-14. PubMed ID: 24914239
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The late complications of diabetes mellitus.
    Squadrito G; Cucinotta D
    Ann Ital Med Int; 1991; 6(1 Pt 2):126-36. PubMed ID: 1742148
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of long-term treatment (4 years) with pentoxifylline on haemorheological changes and vascular complications in diabetic patients.
    Ferrari E; Fioravanti M; Patti AL; Viola C; Solerte SB
    Pharmatherapeutica; 1987; 5(1):26-39. PubMed ID: 3602021
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Complications of diabetes mellitus in childhood.
    Glastras SJ; Mohsin F; Donaghue KC
    Pediatr Clin North Am; 2005 Dec; 52(6):1735-53. PubMed ID: 16301091
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Associations between clinical characteristics and chronic complications in latent autoimmune diabetes in adults and type 2 diabetes.
    Lu J; Hou X; Zhang L; Hu C; Zhou J; Pang C; Pan X; Bao Y; Jia W
    Diabetes Metab Res Rev; 2015 May; 31(4):411-20. PubMed ID: 25448723
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cumulative glycemic exposure and microvascular complications in insulin-dependent diabetes mellitus. The glycemic threshold revisited.
    Orchard TJ; Forrest KY; Ellis D; Becker DJ
    Arch Intern Med; 1997 Sep; 157(16):1851-6. PubMed ID: 9290544
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Cardiovascular autonomic neuropathy and nephropathy in patients with type-1 diabetes mellitus].
    Galicka-Latała D; Fedak D; Kuźniewski M; Kawalec E; Solnica B
    Przegl Lek; 2004; 61(3):155-8. PubMed ID: 15518324
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reversal of diabetic nephropathy: lessons from pancreas transplantation.
    Fioretto P; Mauer M
    J Nephrol; 2012; 25(1):13-8. PubMed ID: 22241641
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Vascular complications in diabetic pregnancy.
    Kaaja R
    Thromb Res; 2011 Feb; 127 Suppl 3():S53-5. PubMed ID: 21262442
    [TBL] [Abstract][Full Text] [Related]  

  • 53. ISPAD Clinical Practice Consensus Guidelines 2014. Microvascular and macrovascular complications in children and adolescents.
    Donaghue KC; Wadwa RP; Dimeglio LA; Wong TY; Chiarelli F; Marcovecchio ML; Salem M; Raza J; Hofman PL; Craig ME;
    Pediatr Diabetes; 2014 Sep; 15 Suppl 20():257-69. PubMed ID: 25182318
    [No Abstract]   [Full Text] [Related]  

  • 54. Early diabetes-related complications in children and adolescents with type 1 diabetes. Implications for screening and intervention.
    Sochett E; Daneman D
    Endocrinol Metab Clin North Am; 1999 Dec; 28(4):865-82. PubMed ID: 10609124
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Novel biomarkers and therapeutic approaches for diabetic retinopathy and nephropathy: Recent progress and future perspectives.
    Xie Z; Xiao X
    Front Endocrinol (Lausanne); 2022; 13():1065856. PubMed ID: 36506068
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Acute and Chronic Adverse Outcomes of Type 1 Diabetes.
    Longendyke R; Grundman JB; Majidi S
    Endocrinol Metab Clin North Am; 2024 Mar; 53(1):123-133. PubMed ID: 38272591
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diabetic Complications: An Update on Pathobiology and Therapeutic Strategies.
    Nellaiappan K; Preeti K; Khatri DK; Singh SB
    Curr Diabetes Rev; 2022; 18(1):e030821192146. PubMed ID: 33745424
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The pathophysiology of diabetes mellitus: an update (continuing education credit).
    Hernandez CG
    Diabetes Educ; 1989; 15(2):162-9. PubMed ID: 2653756
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The therapeutic potential of VEGF inhibition in diabetic microvascular complications.
    Tremolada G; Lattanzio R; Mazzolari G; Zerbini G
    Am J Cardiovasc Drugs; 2007; 7(6):393-8. PubMed ID: 18076206
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of micronized fenofibrate on microvascular complications of type 2 diabetes: a systematic review.
    Czupryniak L; Joshi SR; Gogtay JA; Lopez M
    Expert Opin Pharmacother; 2016 Aug; 17(11):1463-73. PubMed ID: 27267786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.